Lawrence J Green

6PUBLICATIONS
44CO-AUTHORS
Toxicology (incl. clinical toxicology)Gene and molecular therapyInfant and child healthMedical bacteriologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 16, 2026
Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial.

|Sep 19, 2025
Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic Failure.

Lawrence Green, April Armstrong, George Han

|Jan 12, 2025
Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials.

Linda Stein Gold, James Del Rosso, Benjamin D Ehst

|Feb 27, 2024
Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis.

Amy S Paller, Lawrence J Green, Nanette Silverberg

|Dec 22, 2022
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30th EADV Congress 2021.

Andreas Pinter, Linda Stein Gold, Adam Reich

Pageof 1

Frequent Collaborators

3 joint publications

Linda Stein Gold

2 joint publications

April W Armstrong

2 joint publications

Matthew Zirwas

2 joint publications

Angela Y Moore